Stunning effects in radioiodine therapy of thyroid carcinoma

W Koch, P Knesewitsch, K Tatsch… - Nuklearmedizin …, 2003 - thieme-connect.com
In radioiodine therapy for malignant thyroid disease, the pre-therapeutically administered
iodine-131-dose can reduce the potential of thyroid or thyroid carcinoma cells to absorb the …

Stunning effects in radioiodine therapy of thyroid carcinoma. Existence, clinical effects and ways out

W Koch, P Knesewitsch, K Tatsch, K Hahn - Nuklearmedizin, 2003 - inis.iaea.org
[en] In radioiodine therapy for malignant thyroid disease, the pre-therapeutically
administered iodine-131-dose can reduce the potential of thyroid or thyroid carcinoma cells …

Stunning effects in radioiodine therapy of thyroid carcinoma: existence, clinical effects and ways out

W Koch, P Knesewitsch, K Tatsch… - Nuklearmedizin. Nuclear …, 2003 - europepmc.org
In radioiodine therapy for malignant thyroid disease, the pre-therapeutically administered
iodine-131-dose can reduce the potential of thyroid or thyroid carcinoma cells to absorb the …

Stunning effects in radioiodine therapy of thyroid carcinoma: existence, clinical effects and ways out

W Koch, P Knesewitsch, K Tatsch, K Hahn - Nuklearmedizin, 2003 - hero.epa.gov
In radioiodine therapy for malignant thyroid disease, the pre-therapeutically administered
iodine-131-dose can reduce the potential of thyroid or thyroid carcinoma cells to absorb the …

Stunning effects in radioiodine therapy of thyroid carcinoma. Existence, clinical effects and ways out; Stunningeffekte bei der Radioiodtherapie des …

W Koch, P Knesewitsch, K Tatsch, K Hahn - Nuklearmedizin, 2003 - osti.gov
In radioiodine therapy for malignant thyroid disease, the pre-therapeutically administered
iodine-131-dose can reduce the potential of thyroid or thyroid carcinoma cells to absorb the …

Stunning effects in radioiodine therapy of thyroid carcinoma: existence, clinical effects and ways out

W Koch, P Knesewitsch, K Tatsch… - Nuklearmedizin …, 2003 - pubmed.ncbi.nlm.nih.gov
In radioiodine therapy for malignant thyroid disease, the pre-therapeutically administered
iodine-131-dose can reduce the potential of thyroid or thyroid carcinoma cells to absorb the …